| Bioactivity | SARS-CoV-2-IN-92 (compound 11) inhibits early pandemic and more recent SARS-CoV-2 variants (EC50 = 0.48 μM), as well as SARS-CoV and MERS-CoV. SARS-CoV-2-IN-92 (compound 11) potently and selectively blocks ERα-Glu II[1]. |
| CAS | 2123489-12-1 |
| Formula | C7H12O8S |
| Molar Mass | 256.23 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Melissa Thaler, et al. Epi-Cyclophellitol Cyclosulfate, a Mechanism-Based Endoplasmic Reticulum α-Glucosidase II Inhibitor, Blocks Replication of SARS-CoV-2 and Other Coronaviruses. ACS Cent. Sci. July 25, 2024. |
SARS-CoV-2-IN-92
CAS: 2123489-12-1 F: C7H12O8S W: 256.23
SARS-CoV-2-IN-92 (compound 11) inhibits early pandemic and more recent SARS-CoV-2 variants (EC50 = 0.48 μM), as well as
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.